The detail
Hormone levels fluctuate wildly in perimenopause — single draws often misleading. Multiple FSH draws (cycle day 3, 3 cycles) more useful. Diagnosis primarily clinical based on symptoms + age. POI diagnosis requires FSH >40 on 2 separate draws. AMH useful for fertility window assessment.
Historical context
Direct-to-consumer hormone panels marketed the idea that a blood test can diagnose perimenopause. That collides with how clinicians actually diagnose it — from symptoms and cycle pattern over time, not a single number.
Research landscape
For a woman in the typical perimenopausal age range with characteristic symptoms, routine hormone testing is generally not recommended, because estrogen and FSH fluctuate widely day to day and a single value can mislead. Testing is more useful in specific situations: suspected early or primary ovarian insufficiency (symptoms or absent periods before about age 40), unclear pictures such as prior hysterectomy, evaluating specific conditions (thyroid disease, PCOS, prolactin issues), or confirming menopause when it changes a management decision. Thyroid function, in particular, is worth checking because it mimics many menopausal symptoms.
What providers actually do
A menopause-literate clinician usually diagnoses perimenopause clinically and orders hormone tests selectively — most often to rule out mimics (thyroid) or to investigate an atypical or early presentation — rather than to "confirm" a textbook transition.
Subtle red flags specific to this question
- Symptoms or absent periods before age 40 — this warrants testing for early/primary ovarian insufficiency.
- Fatigue, weight change, and temperature intolerance — ask for thyroid testing, which mimics menopause.
- Being sold an expensive panel to "diagnose perimenopause" in a typical-age woman — often unnecessary.
- Galactorrhea (milky discharge) or visual changes with cycle changes — check prolactin and seek evaluation.
Sources
Was this helpful?